Tag: medical device

ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXPLORES HOW INCENTIVES COULD SUPPORT EFFECTIVENESS RESEARCH OF MEDICAL DEVICES

Vienna, Austria—1 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a workshop this morning on Incentivizing Research Into the Effectiveness of Medical Devices at the Society’s 19th Annual European Congress in Vienna, Austria. 

Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR SPECIAL INTEREST GROUP RECOMMENDS CHANGES TO HEALTH TECHNOLOGY ASSESSMENTS FOR MOLECULAR DIAGNOSTICS

Issues Nine Specific Recommendations to Address Identified Challenges Princeton, NJ—August 30, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Medical Devices and Diagnostics Special Interest Group has completed a review of diagnostic-specific health technology assessment programs, identified elements representing

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , ,

ISPOR PUBLISHES NEW GLOBAL HEALTH CARE SYSTEMS ROAD MAP: AUSTRALIA MEDICAL DEVICES

Princeton, NJ—May 2, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that it has published a new Global Health Care Systems Road Map—Australia Medical Devices.

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , ,

ISPOR 18th ANNUAL EUROPEAN CONGRESS ISSUE PANEL EXAMINES SYNERGY BETWEEN HTA AND REGULATORY AGENCIES

SESSION EXPLORES OPPORTUNITIES AND CHALLENGES FOR MEDICAL DEVICES Milan, Italy—November 9, 2015—The International Society for Pharmacoeconomics and Outcomes

Posted in Announcements, ISPOR News & Press Tagged with: , , , , ,

ISPOR EUROPEAN CONGRESS FOCUSES ON “IMPACTING HEALTH DECISION MAKING WITH OUTCOMES RESEARCH”

18th ANNUAL CONGRESS TO BE HELD 7-11 NOVEMBER, 2015 IN MILAN, ITALY  Princeton, NJ—November 2, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced confirmation of key scientific sessions for its 18th Annual European Congress starting next week, 7-11

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , , ,

WHAT`S GOING ON WITH THE TURKISH ORPHAN DRUGS MARKET?

Ankara, Turkey – Many countries and regions have already defined health policies on orphan drugs for rare diseases. Although there is no official definition in Turkey, all orphan drugs are covered by reimbursement, regardless of their market authorization status.

Posted in Announcements, Health Policy Analyses, Value in Health Regional Issues Tagged with: , , , , , , , ,

A New Approach To Korea’s Reimbursement Coverage And Pricing Rules For Medical Devices Long Overdue

Seoul, South Korea – Since 1989, Korea has had a comprehensive National Health Insurance system, which also covers most implantable and disposable medical devices. Although medical devices account for only about 4% of the total budget, considerable attention is paid to

Posted in Policy Perspectives, Value in Health Tagged with: , , , , ,

Does an Official Positive List of Medical Devices Exist?

Istanbul, Turkey – Official positive list practices revealing the reimbursement status of medical devices globally has become a significant benchmark for decision makers. Considering this fact, it is crucial to explicate whether an official positive list of reimbursed medical devices exists

Posted in Health Policy Analyses, ISPOR CONNECTIONS, Value & Outcomes Spotlight Tagged with: , ,

How to Get into Turkey’s Medical Device Market?

Ankara, Turkey  – Despite the global economic crisis, Turkey has one of the most attractive economies due to its growing health care sector. As a result of this growth, the market for medial devices in Turkey is also growing. The 2010 figures

Posted in ISPOR CONNECTIONS, Value & Outcomes Spotlight Tagged with: , ,